 |
|
|
| |
The Association of Circulating MicroRNAs (miRs) With Liver Fibrosis Stage
and the Impact of Selonsertib Treatment in Patients With NASH
|
| |
| |
Reported by Jules Levin
EASL 2018 April 11-15 Paris France
Michael Charlton,1 Anna Mae Diehl,2 Nandita Sarkar,3 Biao Li,3 LuLu Wang,3 Andrew Billin,3 C. Stephen Djedjos,3 G. Mani Subramanian,3 Robert P. Myers,3 Nezam Afdhal,4 Stephen Caldwell,5 Zachary Goodman,6 Rohit Loomba7
1University of Chicago, Illinois, USA; 2Duke Clinical Research Institute, Durham, North Carolina, USA; 3Gilead Sciences, Inc., Foster City, California, USA; 4Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA; 5University of Virginia, Charlottesville, Virginia, USA; 6Inova Fairfax Hospital, Falls Church, Virginia, USA; 7UC San Diego, California, USA
References
1. Hayes CN, Chayama K. Int J Mol Sci 2016;17:280;
2. Naderi M. et al. Arch Iran Med 2017;20:165-71;
3. Jiang XP, et al. Cell Biosci 2017;7:34;
4. Tian XF, et al. PLoS One 2016;11:e0158657;
5. Loomba R, et al. Hepatology 2017 [epub];
6. Phipson B, et al. Ann Appl Stat 2016;10:946-63;
7. Croner LJ, et al. Clin Proteomics 2017;14:28;
8. Baffy G. J Clin Med 2015;4:1977-88;
9. Tili E, et al. Int Rev Immunol 2009;28:264-84.
|
| |
|
|
|
|
|
